Page 102 - scheppingen
P. 102

 four
100
References
1. Djaballah H, Rowe AJ, Harding SE, Rivett AJ. The multicatalytic proteinase complex (proteasome): structure and conformational changes associated with changes in proteolytic activity. Biochem J. 1993 Jun 15;292 ( Pt 3):857-62.
2. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem. 1996;65:801-47.
3. Orlowski M, Wilk S. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase com- plex. Arch Biochem Biophys. 2000 Nov 1;383(1):1-16.
4. Jung T, Grune T. The proteasome and the degradation of oxidized proteins: Part I-structure of proteasomes. Redox Biol. 2013;1(1):178-82.
5. Groll M, Ditzel L, Lowe J, et al. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature. 1997 Apr 3;386(6624):463-71.
6. Tai HC, Besche H, Goldberg AL, Schuman EM. Characterization of the Brain 26S Proteasome and its Interacting Proteins. Front Mol Neurosci. 2010;3.
7. Aki M, Shimbara N, Takashina M, et al. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem. 1994 Feb;115(2):257-69.
8. Tanaka K, Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol Rev. 1998 Jun;163:161-76.
9. Groettrup M, Kirk CJ, Basler M. Proteasomes in immune cells: more than peptide producers? Nat Rev Immunol. 2010 Jan;10(1):73-8.
10. Hensley SE, Zanker D, Dolan BP, et al. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J Immunol. 2010 Apr 15;184(8):4115-22.
11. Kruger E, Kloetzel PM. Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. Curr Opin Immunol. 2012 Feb;24(1):77-83.
12. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, et al. Neuronal induction of the immunopro- teasome in Huntington’s disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2003 Dec 17;23(37):11653-61.
13. Puttaparthi K, Elliott JL. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol. 2005 Dec;196(2):441-51.
14. Orre M, Kamphuis W, Dooves S, et al. Reactive glia show increased immunoproteasome activity in Alzheimer’s disease. Brain. 2013 May;136(Pt 5):1415-31.
15. Bendotti C, Marino M, Cheroni C, et al. Dysfunction of constitutive and inducible ubiquitin-prote- asome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog Neurobiol. 2012 May;97(2):101-26.
16. Jansen AH, Reits EA, Hol EM. The ubiquitin proteasome system in glia and its role in neurodegen- erative diseases. Front Mol Neurosci. 2014;7:73.
17. Mishto M, Ligorio C, Bellavista E, et al. Immunoproteasome expression is induced in mesial tempo- ral lobe epilepsy. Biochem Biophys Res Commun. 2011 Apr 29;408(1):65-70.
18. Mishto M, Raza ML, de Biase D, et al. The immunoproteasome beta5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy. Brain Behav Immun. 2015 Oct;49:188-96.
19. Wong M. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations. Exp Neurol. 2013 Jun;244:22-6.
20. Aronica E, Crino PB. Epilepsy Related to Developmental Tumors and Malformations of Cortical Development. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2014 Jan 31.
21. Blumcke I, Spreafico R. An international consensus classification for focal cortical dysplasias. Lancet neurology. 2011 Jan;10(1):26-7.
22. Samueli S, Abraham K, Dressler A, et al. Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management. Wien Klin Wochenschr. 2015 Aug;127(15-16):619-30.
23. Vasuri F, Capizzi E, Bellavista E, et al. Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrho- sis. Biochem Biophys Res Commun. 2010 Jun 25;397(2):301-6.
24. Mishto M, Bellavista E, Santoro A, et al. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer’s disease brains. Neurobiol Aging. 2006 Jan;27(1):54-66.








































































   100   101   102   103   104